Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk.
Key result
The incidence of sudden death in hypertrophic cardiomyopathy is estimated at 2-4% per year in adults and 4-6% per year in children and adolescents.
Population
Patients with hypertrophic cardiomyopathy
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
High sudden death rates in HCM, especially youth, warrant refined risk stratification now; literature review leaves optimal prevention strategies open.
Key Points
- The research aims to identify patients with hypertrophic cardiomyopathy who are at increased risk of sudden death, focusing on young patients.
- Assessment of the annual incidence of sudden death in adults and children with hypertrophic cardiomyopathy.
- Review of data from referral cardiac centers to analyze patient risk profiles.
- The incidence of sudden death is reported as 2-4% per year in adults and 4-6% in children and adolescents.
- Identification and management of high-risk patients, especially the young, remains a critical challenge.
Structured PICO
P
Population
Patients with hypertrophic cardiomyopathy
Identifying and managing patients with hypertrophic cardiomyopathy at high risk of sudden death remains a major clinical challenge.
Limitations
- Data generated from referral cardiac centers may reflect a bias to the more severe patients.
- Data generated from referral cardiac centers may reflect a bias to more severe patients
Cite This Study
McKenna et al. (1989) conducted a review in Hypertrophic cardiomyopathy. The incidence of sudden death in hypertrophic cardiomyopathy is estimated at 2-4% per year in adults and 4-6% per year in children and adolescents.